Acute Porphyria Drug Database

C01EA01 - Alprostadil
Not porphyrinogenic
NP

Rationale
Endogenous prostaglandin. No relevant CYP metabolism.
Chemical description
Prostaglandin E1.
Therapeutic characteristics
Alprostadil is used mainly in congenital heart disease and in erectile dysfunction.
Metabolism and pharmacokinetics
Metabolized in the lungs and excreted within 24 hours.
Preclinical data
None
Personal communication
None
Published experience
None

Similar drugs
Explore alternative drugs in similar therapeutic classes C01E / C01EA or go back.

 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙